Featured Research

from universities, journals, and other organizations

MRI Improves Treatment Of Deforming Birthmarks

Date:
October 28, 2004
Source:
Radiological Society Of North America
Summary:
Magnetic resonance (MR) guidance may improve the long-term success of treatment for low-flow vascular malformations, according to a study published in the November issue of the journal Radiology.

OAK BROOK, Ill. - Magnetic resonance (MR) guidance may improve the long-term success of treatment for low-flow vascular malformations, according to a study published in the November issue of the journal Radiology.

A low-flow vascular malformation is a deforming birthmark or growth consisting of enlarged veins. While the majority of vascular malformations remain stable throughout a patient's life, others worsen over time and result in disfigurement, bleeding or functional impairment. The condition can be difficult to treat because the veins are poorly defined and send small extensions into neighboring tissues that may be overlooked during standard therapy.

"Under MR imaging they're as bright as light bulbs," said study co-author Jonathan S. Lewin, M.D., formerly with the University Hospitals of Cleveland, now a professor of radiology and radiology department chair at Johns Hopkins School of Medicine in Baltimore. "Detecting and delineating these malformed veins becomes extremely simple."

The common method for treating low-flow vascular malformations is percutaneous sclerotherapy, a minimally invasive treatment in which radiologists inject a sclerosing agent into the malformation, causing the swollen veins to constrict.

While MR imaging has previously been used to diagnose vascular malformations and conduct follow-up examinations after sclerotherapy, this study demonstrated that it can be safely and effectively used during the procedure.

"We can use MR guidance to place the needle, to determine how much therapeutic mixture is needed to fill the malformation, and to monitor the therapeutic agent as it is injected," Dr. Lewin said. "The real benefit for the patient is the ability to ensure that the entire malformation is being treated."

Dr. Lewin and colleagues performed MR-guided percutaneous sclerotherapy on 15 patients with low-flow vascular malformations who had been unsuccessfully treated in the past. With MR-guidance, the researchers successfully treated all predominant symptoms without complications. At follow-up, the targeted areas continued to exhibit significant shrinkage.

"Marrying the unique advantages of interventional MR imaging to current minimally invasive therapy has tremendous potential advantages in a broad array of procedures," Dr. Lewin said.

###

Radiology is a monthly scientific journal devoted to clinical radiology and allied sciences. The journal is edited by Anthony V. Proto, M.D., School of Medicine, Virginia Commonwealth University, Richmond, Va. Radiology is owned and published by the Radiological Society of North America, Inc. (RSNA.org/radiologyjnl)

The Radiological Society of North America (RSNA) is an association of more than 35,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill. (RSNA.org)

---

"Low-Flow Vascular Malformations: MR-guided Percutaneous Sclerotherapy in Qualitative and Quantitative Assessment of Therapy and Outcome." Collaborating with Dr. Lewin on this paper were Daniel T. Boll, M.D., and Elmar M. Merkle, M.D., of University Hospitals of Cleveland.


Story Source:

The above story is based on materials provided by Radiological Society Of North America. Note: Materials may be edited for content and length.


Cite This Page:

Radiological Society Of North America. "MRI Improves Treatment Of Deforming Birthmarks." ScienceDaily. ScienceDaily, 28 October 2004. <www.sciencedaily.com/releases/2004/10/041027143901.htm>.
Radiological Society Of North America. (2004, October 28). MRI Improves Treatment Of Deforming Birthmarks. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2004/10/041027143901.htm
Radiological Society Of North America. "MRI Improves Treatment Of Deforming Birthmarks." ScienceDaily. www.sciencedaily.com/releases/2004/10/041027143901.htm (accessed July 25, 2014).

Share This




More Matter & Energy News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Europe's Highest Train Turns 80 in French Pyrenees

Europe's Highest Train Turns 80 in French Pyrenees

AFP (July 25, 2014) Europe's highest train, the little train of Artouste in the French Pyrenees, celebrates its 80th birthday. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
TSA Administrator on Politics and Flight Bans

TSA Administrator on Politics and Flight Bans

AP (July 24, 2014) TSA administrator, John Pistole's took part in the Aspen Security Forum 2014, where he answered questions on lifting of the ban on flights into Israel's Tel Aviv airport and whether politics played a role in lifting the ban. (July 24) Video provided by AP
Powered by NewsLook.com
Creative Makeovers for Ugly Cellphone Towers

Creative Makeovers for Ugly Cellphone Towers

AP (July 24, 2014) Mobile phone companies and communities across the country are going to new lengths to disguise those unsightly cellphone towers. From a church bell tower to a flagpole, even a pencil, some towers are trying to make a point. (July 24) Video provided by AP
Powered by NewsLook.com
Algonquin Power Goes Activist on Its Target Gas Natural

Algonquin Power Goes Activist on Its Target Gas Natural

TheStreet (July 23, 2014) When The Deal's Amanda Levin exclusively reported that Gas Natural had been talking to potential suitors, the Ohio company responded with a flat denial, claiming its board had not talked to anyone about a possible sale. Lo and behold, Canadian utility Algonquin Power and Utilities not only had approached the company, but it did it three times. Its last offer was for $13 per share as Gas Natural's was trading at a 60-day moving average of about $12.50 per share. Now Algonquin, which has a 4.9% stake in Gas Natural, has taken its case to shareholders, calling on them to back its proposals or, possibly, a change in the target's board. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins